The drugmaker should significantly mitigate its most important risk as it develops new products.

Designed to help pharmaceutical and biotechnology organizations navigate evolving global regulatory expectations from the FDA, EMA, and MHRA, this intensive 2-day virtual seminar delivers practical ...

As the global biotechnology industry continues to advance, **Shanghai Sunite Biotechnology Co., Ltd.** has strengthened its position as a leading Therapeutic and Pharmaceutical Peptides manufacturer ...

This risk is weighing on the stock.

Clinical-stage biopharmaceutical company Tonix Pharmaceuticals (NASDAQ: TNXP) is gaining significant attention from investors and market participants. The company develops therapies for conditions ...

VanEck targets established pharma giants with lower costs and volatility, while Invesco pursues high-growth biotech companies. One delivered stronger returns; the other weathered downturns better.

Strong biotech returns, major pharma acquisitions and new IPO filings are reshaping the 2026 U.S. listing market.

DUBLIN--(BUSINESS WIRE)--The "Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2020-2025" has been added to ResearchAndMarkets.com's offering. This report contains a comprehensive ...

Biotech ETFs can help investors capitalize on health care innovation while avoiding the boom-or-bust nature of individual firms.

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Several recent developments explain why the market is increasingly excited about Vertex Pharmaceuticals' prospects. First, the company recently received a label expansion for Casgevy, a gene-editing ...

Global biotech firms are increasingly being drawn to Hong Kong for its growing investor base and proximity to Chinese pharmaceutical partners.